Protalix BioTherapeutics (PLX) SEC Filings & 10K Form $2.40 -0.20 (-7.50%) As of 01:02 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share SEC Filings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock Recent Protalix BioTherapeutics SEC Filings All Filing Types 1 10 10-D 10-K 10-M 10-Q 11-K 12b-25 13F 13H 144 15 15F 17-H 18 18-K 19b-4(e) 19b-4 19b-7 1-A 1-E 1-K 1-N 1-SA 1-U 1-Z 20-F 24F-2 25 2-E 3 4 40-F 5 6-K 7-M 8-A 8-K 8-M 9-M ABS DD-15E ABS-15G ABS-EE ADV ADV-E ADV-H ADV-NR ADV-W ATS ATS-R BD BD-N BDW C CA-1 CB CFPORTAL D F-1 F-10 F-3 F-4 F-6 F-7 F-8 F-80 F-N F-X ID MA MA-I MA-NR MA-W MSD MSDW n/a N-14 N-17D-1 N-17f-1 N-17f-2 N-18f-1 N-1A N-2 N-23c-3 N-27D-1 N-3 N-4 N-5 N-54A N-54C N-6 N-6EI-1 N-6F N-8A N-8B-2 N-8B-4 N-8F N-CR N-CSR N-MFP N-PX N-Q NRSRO N-SAR PF PILOT R31 S-1 S-11 S-20 S-3 S-4 S-6 S-8 SBSE SBSE-A SBSE-BD SBSE-C SBSE-W SCI SD SDR SE SF-1 SF-3 SIP T-1 T-2 T-3 T-4 T-6 TA-1 TA-2 TA-W TCR TH WB-APP X-17A-19 X-17A-5 Part I X-17A-5 Part II X-17A-5 Part IIA X-17A-5 Part IIB X-17A-5 Part III X-17A-5 Schedule I X-17F-1A Filing Types Include Ownership Filings Exclude Ownership Filings Only Show Ownership FIlings Ownership Filings Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel DateFilerForm TypeView03/17/20254:19 PMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 03/17/20256:18 AMProtalix BioTherapeutics (Filer)Form 10-KAnnual report pursuant to Section 13 or 15(d) 03/17/20255:55 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/31/20243:30 PMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 12/23/20246:01 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/14/20246:03 AMProtalix BioTherapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 11/14/20245:57 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 11/05/20244:00 PMProtalix BioTherapeutics (Issuer)Rubin Eyal (Reporting)Form 4/A10/25/20243:23 PMProtalix BioTherapeutics (Subject)WHITEBOX ADVISORS LLC (Filed by)Form SC 13G/A10/25/20247:27 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 09/24/20244:00 PMNaos Yaron (Reporting)Protalix BioTherapeutics (Issuer)Form 4Statement of changes in beneficial ownership of securities 09/24/20244:00 PMProtalix BioTherapeutics (Issuer)Rubin Eyal (Reporting)Form 4Statement of changes in beneficial ownership of securities 08/14/20246:02 AMProtalix BioTherapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 08/14/20245:56 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) 05/10/20246:20 AMProtalix BioTherapeutics (Filer)Form 10-QGeneral form for quarterly reports under Section 13 or 15(d) 05/10/20245:59 AMProtalix BioTherapeutics (Filer)Form 8-KCurrent report pursuant to Section 13 or 15(d) (Data available from 1/1/2016 forward) Remove Ads Related Companies and Tools Related Companies CMRX SEC Filings EOLS SEC Filings PRAX SEC Filings AVDL SEC Filings REPL SEC Filings XNCR SEC Filings NTLA SEC Filings AVXL SEC Filings GYRE SEC Filings RCKT SEC Filings SEC Filings Tools Latest SEC FilingsInsider Trading Activity This page (NYSE:PLX) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | SponsoredThe bigger story behind the recent market pullbackNearly $3 trillion disappeared from the stock market on Thursday morning. According to Whitney Tilson - a f...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Protalix BioTherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLX Stock Free PLX Stock Alerts